Impact Factor
3.53
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.21
495 total citations
h5-index
32
h5 depth signal
Cited share
81.3%
130 of 160
Total citations
495
Citation footprint
Metric signal
3.39
External metric anchor
Self-citation
10.3%
51 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
755
China
288
United States
41
South Korea
31
Thailand
11
Citing Fields of Research
Physiology
170
Neurosciences
123
Cellular Membrane Transporters & Receptors
121
Cardiology
121
Neurodegenerative Disorders
119
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,517
Articles tracked across the journal lifetime
Indexed publication set
160
130 cited publications
Last 12 months
78
6.5 publications/month
Open access share
100.0%
78 OA publications in the last year
Leading citing country
Japan
755 citing publications
Leading citing field
Physiology
170 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v91n1,Jan. 2003-
v91n1,Jan. 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurosciences
Physiology
Neurodegenerative Disorders
Cancer, Autophagy & Apoptosis
Cardiology
Immunology
Anesthetic & Pain Medicine
Issuing & Sponsoring Bodies
Contributor
Nihon Yakuri Gakkai
Broad Categories
Pharmacology
Neurosciences
Cancer, Autophagy & Apoptosis
Physiology
Cardiology
Molecular Pharmacology
Cellular Membrane Transporters & Receptors
Gut-Brain Axis Disorders
MeSH Descriptors
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jphs.2026.10.002
Open DOI
Dynamic trajectories of electrolytes and bone metabolism with tofogliflozin and glimepiride: A post-hoc analysis
02
03
DOI 10.1016/j.jphs.2026.10.001
Open DOI
Phenylbutyrate Derived Nitric Oxide Donor attenuates by renal fibrosis through extracellular matrix degradation pathway
04
05
06
07
DOI 10.1016/j.jphs.2026.09.003
Open DOI
Nobiletin differentially regulates muscarinic and nicotinic receptor–mediated ERK signaling
08
DOI 10.1016/j.jphs.2026.09.002
Open DOI
Melatonin ameliorates diabetic retinopathy by inhibiting PANoptosis via the LncSNHG5/miR-26a-5p/Hippo signaling axis
09
10
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 91, no. 2 (Feb. 2003)
Also issued online.
Official publication of the Japanese Pharmacological Society.